Recent changes in influenza vaccination recommendations, 2007

Journal of Family Practice

Volumn 56, Issue SUPPL. 2, 2007, Pages

  Zimmerman, Richard Kent ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; LIVE ATTENUATED INFLUENZA VACCINE; SALICYLIC ACID DERIVATIVE; THIOMERSAL; TRIVALENT INACTIVATED INFLUENZA VACCINE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; CHILD HOSPITALIZATION; CLINICAL TRIAL; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; FEVER; HEADACHE; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; MALAISE; MORTALITY; MYALGIA; NOSE CONGESTION; PNEUMONIA; REVIEW; RHINORRHEA; SEROCONVERSION; SYSTEMATIC REVIEW; UNITED STATES; VOMITING;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PREGNANCY; UNITED STATES; VACCINES, INACTIVATED; WORLD HEALTH;

EID: 33847169050     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Thompson W, Shay D, Weintraub E, Brammer L, Anderson L, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179-186.
2. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292:1333-1340.
3. Neuzil KM, Wright PF, Mitchel EF, Griffin MR. Burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr. 2000;137:856-864.
4. Smith NM, Bresee JS, Shay DK, Uyeki TM, Cox NJ, Strikas RA; for the Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) !published correction appears in MMWR Morb Mortal Wkly Rep. 2006;55(29):8001. MMWR Recomm Rep. 2006;55(RR-10):1-42.
5. Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Griffin MR. The effect of influenza on hospitalization, outpatient visits, and courses of antibiotics in children. N Engl J Mea. 2000;342:225-231.
6. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342;232-239.
7. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 2000;283:499-505.
8. Sullivan KM, Monto AS, Longini IM Jr. Estimates of the US health impact of influenza. Am J Public Health. 1993;83:1712-1716.
9. Strassburg MA, Greenland S, Sorvillo FJ, Lieb LE, Habel LA. Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine. 1986;4:38-44.
10. Meiklejohn G, Hall H. Unusual outbreak of influenza A in a Wyoming nursing home. J Am Geriatr Soc. 1987;35:742-746.
11. Goodman RA, Orenstein WA, Munro TF, Smith SC, Sikes RK. Impact of influenza A in a nursing home. JAMA. 1982;247:1451-1453.
12. Glezen WP. Consideration of the risk of influenza in children and indications for prophylaxis. Rev Infect Dis. 1980;2:408-420.
13. Glezen WP, Taber LH, Frank AL, Gruber WC, Piedra PA. Influenza virus infections in infants. Pediatr Infect Dis J. 1997;16:1065-1068.
14. Glezen WP, Couch RB, Taber LH, et al. Epidemiologic observations of influenza B virus infections in Houston, Texas, 1976-1977. Am J Epidemiol. 1980;111:13-22.
15. Monto AS, Davenport FM, Napier JA, Francis T Jr. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis. 1970;122:16-25.
16. Rudenko LG, Slepushkin AN, Monto AS, et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis. 1993;168:881-887.
17. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med. 2001;344:889-896.
18. Cha TA, Kao K, Zhao J, Fast PE, Mendelman PM, Arvin A. Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial. J Clin Microbiol. 2000;38;839-845.
19. Neuzil KM, Dupont WD, Wright PF, Edwards KM. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J. 2001;20:733-740.
20. Clover RD, Crawford S, Glezen WP, Taber LH, Matson CC, Couch RB. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. J Infect Dis. 1991;163:300-304.
21. Hoberman A, Greenberg DP, Paradise JL, et al. Effectiveness of inactivated influenza vaccine in preventing acute oritis media in young children. JAMA. 2003;290:1608-1616.
22. Nichol KL, Lind A, Margolis KL, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med. 1995;333:889-893.
23. Foster DA, Talsma A, Furumoto-Dawson A, et al. Influenza vaccine effectiveness in preventing hospitalization from pneumonia in the elderly. Am J Epidemiol. 1992;13:296-307.
24. Fedson DS, Wajda A, Nicol JP, Hammond GW, Kaiser DL, Roos LL. Clinical effectiveness of influenza vaccine in Manitoba [published correction appears in JAMA. 1994;271:1578]. JAMA. 1993;270;1956-1961.
25. Barker WH, Mullooly JP. Effectiveness of inactivated influenza vaccine among non-institutionalized elderly persons. In: Options for the Control of Influenza. New York, NY: Alan R. Liss Inc; 1986:169-182.
26. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med. 1995;123:518-527.
27. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA. 1994;272:1661-1665.
28. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg TL. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994;331:778-784.
29. Belshe RB, Gruber WC, Mendelman PM, et al. Efficacy of vaccination with live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr. 2000;136:168-175.
30. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med. 1998;338:1405-1412.
31. Nichol KL, Mendelman PM, Mallon KP, et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA. 1999;282:137-144.
32. Margolis KL, Nichol KL, Poland GA, Pluhar RE. Frequency of adverse reactions to influenza vaccine in the elderly: a randomized, placebo-controlled trial. JAMA. 1990;307:988-990.
33. American Lung Association Asthma Clinical Research Centers. Safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med. 2001;345:1529-1536.
34. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol. 1979;110:105-123.
35. Juurlink DN, Stukel TA, Kwong J, et al. Guillain-Barré Syndrome after influenza vaccination in adults: a population-based study. Arch Intern Med. 2006;166:2217-2221.
36. Vesikari T. Randomized, double-blind, placebo-controlled trial of the safety, transmissibility and phenotypic stability of a live, attenuated, cold-adapted influenza virus vaccine (CAIV-T) in children attending day care [abstract]. Presented at the 41st Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); December 16-19, 2001; Chicago, Ill. Abstract G-450.
37. Talbot TR, Crocker DD, Peters J. Degree and duration of mucosal shedding following use of trivalent intranasal live attenuated influenza vaccine in adults [abstract]. Presented at 14th Annual Meeting, Society for Healthcare Epidemiology in America (SHEA); April 18-20, 2004; Philadelphia, Pa.
38. MedImmune. Safety and efficacy of cold-adapted influenza vaccine (CAIV-T) [slide presentation]. Presented to the Advisory Committee on Immunization Practices; October 25, 2006. Available at: http://www.cdc.gov/nip/acip/slides/ oct06/04_Influenza/influenza-3-medimmune.pdf. Accessed December 4, 2006.
39. Murphy KR, Strunk RC. Safe administration of influenza vaccine in asthmatic children hypersensitive to egg proteins. J Pediatr. 1985;106:931-933.